Tags

Type your tag names separated by a space and hit enter

Real-time transrectal ultrasound-guided seminal vesiculoscopy for the treatment of patients with persistent hematospermia: A single-center, prospective, observational study.
Asian J Androl. 2020 Sep-Oct; 22(5):507-512.AJ

Abstract

This study aimed to describe endoscopic anatomy of the seminal tract and summarize our experience of transutricular seminal vesiculoscopy (TSV) guided by real-time transrectal ultrasonography (TRUS) in managing persistent hematospermia. A total of 281 consecutive patients with persistent hematospermia who underwent TSV with or without real-time TRUS were enrolled in this single-center, prospective, observational study. The median follow-up period was 36.5 (range: 8.0-97.5) months. TSV was successfully performed in 272 (96.8%) patients. The approach of a 4.5/6 F rigid vesiculoscope entering the seminal tract was categorized into four types on the basis of endoscopic presentation of the ejaculatory duct orifice and verumontanum. Seven (2.6%), 74 (27.2%), 64 (23.5%), and 127 (46.7%) patients had Types I (through the ejaculatory duct in the urethra), II (through the ejaculatory duct in the prostatic utricle), III (transutricular fenestration through a thin membrane), and IV (real-time transrectal ultrasound-guided transutricular fenestration) approach, respectively. In patients who successfully underwent surgery, bleeding occurred in the seminal vesicle in 249 (91.5%) patients. Seminal vesiculitis, calculus in the prostatic utricle, calculus in the ejaculatory duct, calculus in the seminal vesicle, prostatic utricle cysts, and seminal vesicle cysts were observed in 213 (78.3%), 96 (35.3%), 22 (8.1%), 81 (29.8%), 25 (9.2%), and 11 (4.0%) patients, respectively. Hematospermia was alleviated or disappeared in 244 (89.7%) patients 12 months after surgery. Fifteen patients had recurrent hematospermia, and the median time to recurrence was 7.5 (range: 2.0-18.5) months. TSV guided by TRUS may contribute to successful postoperative outcomes in managing persistent hematospermia.

Authors+Show Affiliations

Department of Urology, Center for Reproductive Medicine, Shandong University, Jinan 250001, China. Department of Urology, The Second Hospital of Shandong University, Jinan 250033, China.Department of Urology, The Second Hospital of Shandong University, Jinan 250033, China.Department of Urology, The Second Hospital of Shandong University, Jinan 250033, China.Department of Urology, The Second Hospital of Shandong University, Jinan 250033, China.Institute of Urology, Shandong University, Jinan 250033, China.Department of Urology, The Second Hospital of Shandong University, Jinan 250033, China. Institute of Urology, Shandong University, Jinan 250033, China.Department of Urology, The Second Hospital of Shandong University, Jinan 250033, China.Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.

Pub Type(s)

Journal Article
Observational Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31898586

Citation

Wang, Xue-Sheng, et al. "Real-time Transrectal Ultrasound-guided Seminal Vesiculoscopy for the Treatment of Patients With Persistent Hematospermia: a Single-center, Prospective, Observational Study." Asian Journal of Andrology, vol. 22, no. 5, 2020, pp. 507-512.
Wang XS, Li M, Shao GF, et al. Real-time transrectal ultrasound-guided seminal vesiculoscopy for the treatment of patients with persistent hematospermia: A single-center, prospective, observational study. Asian J Androl. 2020;22(5):507-512.
Wang, X. S., Li, M., Shao, G. F., Sun, W. D., Zhang, X. L., Xiao, Z. Y., Ma, Z., Yuan, M. Z., & Guo, L. Q. (2020). Real-time transrectal ultrasound-guided seminal vesiculoscopy for the treatment of patients with persistent hematospermia: A single-center, prospective, observational study. Asian Journal of Andrology, 22(5), 507-512. https://doi.org/10.4103/aja.aja_134_19
Wang XS, et al. Real-time Transrectal Ultrasound-guided Seminal Vesiculoscopy for the Treatment of Patients With Persistent Hematospermia: a Single-center, Prospective, Observational Study. Asian J Androl. 2020 Sep-Oct;22(5):507-512. PubMed PMID: 31898586.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Real-time transrectal ultrasound-guided seminal vesiculoscopy for the treatment of patients with persistent hematospermia: A single-center, prospective, observational study. AU - Wang,Xue-Sheng, AU - Li,Ming, AU - Shao,Guang-Feng, AU - Sun,Wen-Dong, AU - Zhang,Xiu-Lin, AU - Xiao,Zhi-Ying, AU - Ma,Zhen, AU - Yuan,Ming-Zhen, AU - Guo,Li-Qiang, PY - 2020/1/4/pubmed PY - 2021/8/4/medline PY - 2020/1/4/entrez KW - persistent hematospermia KW - seminal vesiculoscopy KW - transrectal ultrasound SP - 507 EP - 512 JF - Asian journal of andrology JO - Asian J Androl VL - 22 IS - 5 N2 - This study aimed to describe endoscopic anatomy of the seminal tract and summarize our experience of transutricular seminal vesiculoscopy (TSV) guided by real-time transrectal ultrasonography (TRUS) in managing persistent hematospermia. A total of 281 consecutive patients with persistent hematospermia who underwent TSV with or without real-time TRUS were enrolled in this single-center, prospective, observational study. The median follow-up period was 36.5 (range: 8.0-97.5) months. TSV was successfully performed in 272 (96.8%) patients. The approach of a 4.5/6 F rigid vesiculoscope entering the seminal tract was categorized into four types on the basis of endoscopic presentation of the ejaculatory duct orifice and verumontanum. Seven (2.6%), 74 (27.2%), 64 (23.5%), and 127 (46.7%) patients had Types I (through the ejaculatory duct in the urethra), II (through the ejaculatory duct in the prostatic utricle), III (transutricular fenestration through a thin membrane), and IV (real-time transrectal ultrasound-guided transutricular fenestration) approach, respectively. In patients who successfully underwent surgery, bleeding occurred in the seminal vesicle in 249 (91.5%) patients. Seminal vesiculitis, calculus in the prostatic utricle, calculus in the ejaculatory duct, calculus in the seminal vesicle, prostatic utricle cysts, and seminal vesicle cysts were observed in 213 (78.3%), 96 (35.3%), 22 (8.1%), 81 (29.8%), 25 (9.2%), and 11 (4.0%) patients, respectively. Hematospermia was alleviated or disappeared in 244 (89.7%) patients 12 months after surgery. Fifteen patients had recurrent hematospermia, and the median time to recurrence was 7.5 (range: 2.0-18.5) months. TSV guided by TRUS may contribute to successful postoperative outcomes in managing persistent hematospermia. SN - 1745-7262 UR - https://www.unboundmedicine.com/medline/citation/31898586/Real_time_transrectal_ultrasound_guided_seminal_vesiculoscopy_for_the_treatment_of_patients_with_persistent_hematospermia:_A_single_center_prospective_observational_study_ L2 - http://www.ajandrology.com/article.asp?issn=1008-682X;year=2020;volume=22;issue=5;spage=507;epage=512;aulast=Wang DB - PRIME DP - Unbound Medicine ER -